Cambridge Investment Research Advisors Inc. Boosts Position in NeoGenomics, Inc. (NASDAQ:NEO)
Cambridge Investment Research Advisors Inc. Boosts Position in NeoGenomics, Inc. (NASDAQ:NEO) Posted by Jay Halladay on Feb 28th, 2021
Cambridge Investment Research Advisors Inc. boosted its position in shares of NeoGenomics, Inc. (NASDAQ:NEO) by 31.6% during the fourth quarter, Holdings Channel reports. The firm owned 10,226 shares of the medical research company’s stock after buying an additional 2,454 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in NeoGeno…
Original Source